EVerZom: Funding, Investors & Team (Sep 2026)
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
EVerZom has raised $17.9M across 3 funding rounds on record, the most recent a Series A of $11.6M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
EVerZom Company Profile and Key Stats
Latest funding round on record: Oct 2025.
EVerZom Funding Rounds
EVerZom raised $2.8M in a Grant announced in Nov 2021.
3.6 years later, an undisclosed round of $3.5M was announced in Jun 2025.
4 months later, a Series A of $11.6M was announced in Oct 2025.
EVerZom Founders and Leadership Team
Contact details for the EVerZom team: 1 of 1 has an email address on file.
Start 14-day free trial →EVerZom Funding Compared to Other Biotechnology Startups
EVerZom's latest round of $11.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like EVerZom in Biotechnology and Paris
Companies Similar to EVerZom
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
EVerZom Funding FAQs
What does EVerZom do?
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
How much funding has EVerZom raised?
EVerZom has raised $17.9M across 3 rounds on record. The most recent is a Series A of $11.6M announced in Oct 2025.
When did EVerZom last raise funding?
EVerZom's most recent funding round on record is a Series A of $11.6M, announced in Oct 2025.
Who founded EVerZom?
FundedIQ lists Jeanne Volatron (Founder) at EVerZom.
Where is EVerZom headquartered?
EVerZom is based in Paris, Ile-De-France, France.
How many employees does EVerZom have?
EVerZom is in the 11-50 employee band.
How does EVerZom's funding compare to other Biotechnology startups?
EVerZom's latest round of $11.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's EVerZom Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EVerZom is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.